306 related articles for article (PubMed ID: 11867836)
1. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF.
Schoch OD; Schanz U; Koller M; Nakata K; Seymour JF; Russi EW; Boehler A
Thorax; 2002 Mar; 57(3):277-80. PubMed ID: 11867836
[TBL] [Abstract][Full Text] [Related]
2. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
[TBL] [Abstract][Full Text] [Related]
3. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.
Latzin P; Tredano M; Wüst Y; de Blic J; Nicolai T; Bewig B; Stanzel F; Köhler D; Bahuau M; Griese M
Thorax; 2005 Jan; 60(1):39-44. PubMed ID: 15618581
[TBL] [Abstract][Full Text] [Related]
4. Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis.
Thomassen MJ; Raychaudhuri B; Bonfield TL; Malur A; Abraham S; Barna BP; Kavuru MS
Autoimmunity; 2003 Aug; 36(5):285-90. PubMed ID: 14567558
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
[TBL] [Abstract][Full Text] [Related]
8. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis.
Tchou-Wong KM; Harkin TJ; Chi C; Bodkin M; Rom WN
Am J Respir Crit Care Med; 1997 Dec; 156(6):1999-2002. PubMed ID: 9412586
[TBL] [Abstract][Full Text] [Related]
9. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
Xu KF; Chen Y; Guo ZJ; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
[TBL] [Abstract][Full Text] [Related]
11. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
[TBL] [Abstract][Full Text] [Related]
12. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
Huizar I; Kavuru MS
Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
[TBL] [Abstract][Full Text] [Related]
13. Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
Ito M; Nakagome K; Ohta H; Akasaka K; Uchida Y; Hashimoto A; Shiono A; Takada T; Nagata M; Tohyama J; Hagiwara K; Kanazawa M; Nakata K; Tazawa R
BMC Pulm Med; 2017 Feb; 17(1):40. PubMed ID: 28212655
[TBL] [Abstract][Full Text] [Related]
14. SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.
Douda DN; Farmakovski N; Dell S; Grasemann H; Palaniyar N
Orphanet J Rare Dis; 2009 Dec; 4():29. PubMed ID: 20030831
[TBL] [Abstract][Full Text] [Related]
15. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.
Bonfield TL; Raychaudhuri B; Malur A; Abraham S; Trapnell BC; Kavuru MS; Thomassen MJ
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1132-6. PubMed ID: 12896880
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction.
Greenhill SR; Kotton DN
Chest; 2009 Aug; 136(2):571-577. PubMed ID: 19666756
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Alveolar Proteinosis Syndrome.
Suzuki T; Trapnell BC
Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chang GD; Chern MS; Chen YC; Chang SC
Thorax; 2006 Jun; 61(6):528-34. PubMed ID: 16517574
[TBL] [Abstract][Full Text] [Related]
19. Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.
Malur A; Kavuru MS; Marshall I; Barna BP; Huizar I; Karnekar R; Thomassen MJ
Respir Res; 2012 Jun; 13(1):46. PubMed ID: 22697800
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.
Sakagami T; Beck D; Uchida K; Suzuki T; Carey BC; Nakata K; Keller G; Wood RE; Wert SE; Ikegami M; Whitsett JA; Luisetti M; Davies S; Krischer JP; Brody A; Ryckman F; Trapnell BC
Am J Respir Crit Care Med; 2010 Jul; 182(1):49-61. PubMed ID: 20224064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
